TickerFacts.

Compare

AbCellera Biologics Inc. vs Bicycle Therapeutics PLC vs Assembly Biosciences, Inc. vs Eton Pharmaceuticals, Inc.

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal yearAbCellera Biologics Inc.
ABCL		Bicycle Therapeutics PLC
BCYC		Assembly Biosciences, Inc.
ASMB		Eton Pharmaceuticals, Inc.
ETON
Year ended2025-12-312025-12-312025-12-312025-12-31
Revenue$75.13M$72.59M$72.30M$79.95M
Revenue growth (YoY)+160.6%+105.8%+153.5%+104.9%
Gross marginn/an/an/a53.5%
Operating margin-289.0%-340.4%-16.8%-1.1%
Net margin-194.9%-301.7%-8.5%-5.8%
Net income-$146.41M-$218.96M-$6.12M-$4.60M
EPS (Diluted)-$0.49-$3.16-$0.55n/a
Operating cash flow-$131.29M-$249.68M-$41.09M$10.52M
Free cash flow-$174.07M-$252.03M-$41.16M$10.19M
Cash & equivalents$128.51M$628.11M$58.45M$25.94M
Total assets$1.36B$717.60M$257.59M$92.11M
Total liabilities$390.05M$107.62M$50.84M$65.96M
Shareholders' equity$966.90M$609.98M$206.75M$26.15M
Return on year-end equity-15.1%-35.9%-3.0%-17.6%
Shares outstanding300.60M69.37M15.86M27.05M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal yearAbCellera Biologics Inc.Bicycle Therapeutics PLCAssembly Biosciences, Inc.Eton Pharmaceuticals, Inc.
Latest$75.13M
Ended 2025-12-31		$72.59M
Ended 2025-12-31		$72.30M
Ended 2025-12-31		$79.95M
Ended 2025-12-31
1 year earlier$28.83M
Ended 2024-12-31		$35.27M
Ended 2024-12-31		$28.52M
Ended 2024-12-31		$39.01M
Ended 2024-12-31
2 years earlier$38.02M
Ended 2023-12-31		$26.98M
Ended 2023-12-31		$7.16M
Ended 2023-12-31		$31.64M
Ended 2023-12-31
3 years earlier$485.42M
Ended 2022-12-31		$14.46M
Ended 2022-12-31		$0
Ended 2022-12-31		$21.25M
Ended 2022-12-31
4 years earlier$375.20M
Ended 2021-12-31		$11.70M
Ended 2021-12-31		$6.25M
Ended 2021-12-31		$21.83M
Ended 2021-12-31